Foghorn Therapeutics Inc. Impairment of Leasehold
Foghorn Therapeutics Inc. (FHTX) reported Impairment of Leasehold of $800.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLeasehold · last filed 2025-11-05
- Foghorn Therapeutics Inc. impairment of leasehold for the quarter ending 2024-12-31 was $0.00.
- Foghorn Therapeutics Inc. impairment of leasehold for the quarter ending 2024-09-30 was $0.00.
- Foghorn Therapeutics Inc. impairment of leasehold for the quarter ending 2024-06-30 was $800.00K.
- Foghorn Therapeutics Inc. impairment of leasehold for fiscal 2024 was $800.00K.
| Period end | Impairment of Leasehold 3 month | Impairment of Leasehold 6 month | Impairment of Leasehold 9 month | Impairment of Leasehold 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $800.00K derived: sum of 3 quarters · filed 2025-11-05 | $800.00K 10-K · filed 2025-03-06 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $800.00K derived: sum of 2 quarters · filed 2025-11-05 | $800.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $800.00K 10-Q · filed 2025-08-05 | $800.00K 10-Q · filed 2025-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |